Pear is an early-stage venture fund founded by Pejman Nozad and Mar Hershenson. Their co-founding managers have historically seeded very early stage tech start-ups such as Doordash, Guardant Health, Gusto, Viz.ai, Dropbox, Lending Club, Vanta, Zoosk, Addepar, Path and many others. Their motto is simple: they invest in exceptional founders who are building amazing companies. They utilize every resource they have to assist their founders and entrepreneurs shape the future.

Pear VC

Techammer is an angel investor who helps founders solve important problems. Designers invest in data science, digital health, and companies that accelerate science. Companies that improve the lives of ordinary Americans pique our interest. The designers are both Midwesterners (Jeff from Michigan/Indiana and Halle from Ohio), and we both started our careers bagging groceries. Designers met in San Francisco, where we both lived for three months. The designers got married in Italy and just moved to the East Coast.

Techammer

Seedcamp is Europe's seed fund, identifying and investing early in world-class founders attacking large, global markets and solving real problems using technology. The Seedcamp Nation includes over 400 startups building breakout businesses that change the way people live, interact and buy and includes publicly listed UiPath, Wise, and unicorns Revolut, Hopin, Sorare, Pleo, and wefox along with fast-growing businesses such as Grover, viz.ai and Ezra.  Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support and a global network built upon more than a decade's experience backing exceptional talent. Seedcamp fast-tracks a founder's vision and creates value through immediate access to smart capital, a lifelong community of support, and a global network built upon more than a decade's experience backing exceptional talent.

Seedcamp

Innovation Endeavors is an early-stage venture capital firm that invests in cutting-edge technologies to drive generational change in order to solve problems that matter. The firm’s central investment thesis, the Super Evolution, combines data, computational capacity, and advanced engineering to transform a range of industries including engineering health, climate, computing infrastructure, intelligent software, the physical economy, and more. Its investments include Afresh, AlphaSense, Atom Computing, Color, Gatik, Eikon Therapeutics, Fabric, Homelight, Kong, Formlabs, Panther, Planet, Replica, SoFi, Uber, Upstart, Vicarious Surgical, and more. For more information, visit www.InnovationEndeavors.com.

Innovation Endeavors

AME Cloud Ventures focuses on seed to later stage companies building infrastructure and value chains around data. It specializes in technology-heavy companies gathering or creating unique data at every stage of the data stack — from infrastructure all the way to applications, mobile, and sensors.  It strives to find, fund, and support true entrepreneurs. The firm provides a unique and genuine set of resources to our founding teams, from strong operational and business experience to networks of amazing mentors and international partners, particularly in China. AME Cloud Ventures is the venture fund led by Jerry Yang, co-founder of Yahoo!

AME Cloud Ventures

Susa Ventures is an early-stage venture capital firm investing primarily in seed rounds. The firm was founded in October 2013 and si headquartered in San Francisco, California, United States.

Susa Ventures

DHVC is a venture capital firm based in Palo Alto, California. We invest in Enterprise, Consumer, FinTech, and Healthcare sectors. Our team brings together decades of combined experience in entrepreneurship, operations, investment, and research to serve our portfolio companies in growing and achieving success.

DHVC

Kleiner Perkins is a venture capital firm specializing in investing in early-stage, growth, and incubation companies. The firm continues that legacy, investing in founders with bold ideas that span industries and continents, partnering with them from inception to IPO and beyond to maximize the potential of their ideas. They also focus on early computer firms using their devices and programming and service companies. It also invests in the digital, life sciences, and healthcare industries.

Kleiner Perkins

Google Ventures invests in sectors including life sciences, consumer, enterprise, crypto, climate, and frontier technology. With Alphabet as its sole limited partner, Google Ventures focuses on long-term investments. Its operating partners assist startups in design, equity, diversity & inclusion, talent, and engineering and help them connect with Google for technology and expertise. Founded in 2009 as Google Ventures, Google Ventures manages over $8 billion in assets with 400 active portfolio companies in North America and Europe. Some notable investments include Uber, Nest, Slack, GitLab, and One Medical. Google Ventures is based in the San Francisco Bay Area with offices in Cambridge, New York, and London.

Google Ventures

‍Greenoaks makes concentrated, long-term investments in generational teams building enduring companies. The firm invests behind exceptional leaders early in their journeys, building partnerships that endure for decades.

Greenoaks

CRV has been an investor in technology companies for almost half a century. The firm has backed nearly 400 startups in its 47-year history, including foundational companies like Twitter, Zendesk, Amgen, Hubspot, Parametric Technologies, Yammer, EqualLogic, and Sonus Networks. Half of the companies CRV has backed have gone public or been acquired. The firm focuses on enterprise, consumer, and deep-insight bioengineering.

Threshold is an early-stage venture capital firm that focuses on a high-conviction investment strategy. The firm partners with entrepreneurs to build innovative consumer, enterprise, and healthcare technology companies.

Threshold

Insight Partners is a global software investor that partners with growth-stage technology and software companies. Insight has a deep focus in Fintech, Cybersecurity, AI/ML, DevOps, and Healthcare sectors. Across their people and their portfolio, they encourage a culture around a core belief growth equals opportunity. As of December 31, 2022, the firm has over $75B in regulatory assets under management. Insight Partners has invested in more than 750 companies worldwide and has seen over 55 portfolio companies achieve an IPO.

Insight Partners

Scale Venture Partners is a seed-stage venture capital firm focused on intelligent business software with a Scaling Platform that has helped companies like Box, Bill.com, Hubspot, Docusign, JFrog, and WalkMe move from founder-led growth to a repeatable go-to-market machine. ScaleVP partners with entrepreneurs to support accelerated growth from the first customer to market leadership.

Scale Venture Partners

Founded in 2001, Tiger Global Management, LLC (“Tiger Global”) is a New York-based investment firm pursuing a long-term approach to investing in leading, global public and private companies that leverage technological innovation. Tiger Global’s public equity business includes fundamentally oriented long/short, long-focused and crossover strategies, targeting investments in high-quality, public growth companies. The private equity business invests in early through late stage companies that pursue innovative approaches to new and existing industries, building on over 20 years of experience investing in hundreds of businesses in more than 30 countries with more than 90 portfolio company IPOs. With a strong track record investing across sectors and stages, Tiger Global aims to be a thought partner to companies and their management teams across their lifecycle in public and private markets. The Firm’s mission is to generate world-class returns for its investors and to do so in a way that makes its employees, partners and portfolio companies proud.

Tiger Global Management

Sozo Ventures was formed in 2011 to invest in and support IT ventures with their global expansion. We invest in category leaders in advanced data technologies, ecommerce, enterprise cloud, fintech, IOT and healthcare IT, among other emerging sectors. We are structured to connect the most ambitious entrepreneurial teams with the world's most advanced and respected customers and distributors. We are at our best when we can share our expertise well before expansion strategies are set.

Sozo Ventures

Viz helps physicians to identify anomalies in brain scans through machine learning. The company leverages advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat them. It uses deep learning algorithms to identify a suspected large vessel occlusion, a particularly disabling type of stroke, in a CT scan and alerts the stroke team specialist within minutes. Viz has developed deep learning algorithms to analyze brain scans for large vessel occlusions (LVOs), a disabling type of stroke. The company also allows the stroke center’s clinicians to rapidly share images back and forth. Viz's mission is to fundamentally improve how healthcare is delivered in the world, through intelligent software that promises to reduce the time to treatment and improve access to care. Viz was founded in 2016 and is based in San Francisco, California.

Viz.ai offers an AI-powered integrated care coordination platform called Viz.ai One and develops diagnostic tools to support the early detection of deteriorating patient conditions by cross-referencing a patient’s CT images with its database of scans. The software then alerts healthcare providers and helps triage patients to specialists via its mobile app. The app also allows healthcare providers to view high-quality scans from any location.

Membership-based, non-insurance healthcare companies helping maintain a steady state of well being.

Preventive Healthcare

Viz.ai

New Data Demonstrate Benefits of Viz.ai's Stroke Treatment Tech

Medtronic

Viz.ai and medical device company Medtronic formed a partnership to enhance coordination in the care of cryptogenic stroke patients.

Tools that collect and analyze real-time patient data that supports healthcare providers with clinical decisions,  improves patient outcomes, and reduces medical errors.

Medtronic partners with Viz.ai to accelerate adoption of new artificial intelligence software in U.S. stroke centers

Viz.ai offers an AI-powered integrated care coordination platform called Viz.ai One and develops diagnostic tools to support the early detection of deteriorating patient conditions by cross-referencing a patient’s CT images with its database of scans. The software then alerts healthcare providers and helps triage patients to specialists via its mobile app. The app also allows healthcare providers to view high-quality scans from any location.The Viz.ai One suite includes 1) Viz Vascular, tools for vascular medicine, 2) Viz Neuro, tools for suspected neuro diseases, 3) Viz Cardio, tools for cardiovascular needs, 4) Viz Trauma, 5) Viz Radiology, for radiologists, and 6) Viz Connect, a communication and workflow tool.&nbsp;In 2021, Centers for Medicare &amp; Medicaid Service granted Viz.ai with the New Technology Add-On Payment, an industry first for AI technology in healthcare. This gives hospitals a maximum of USD 1,040 in additional payments per diagnosis for using its AI-enabled stroke intervention. The company has been rapidly expanding its offering, including the launch of a life science platform to perform clinical trials and support a go-to-market strategy.&nbsp;Key customers and partnershipsAs of May 2024, the company has partnered with 1,600 hospitals across the US, Europe, Middle-East and Africa for its AI driven platform.&nbsp;Further in November 2022, the company partnered with Singaporean-based software development company Us2.ai to offer echocardiogram analysis in the Viz Platform. In May 2024, Viz.ai announced the collaboration with the University of Texas Medical Branch (UTMB) to incorporate their Viz Subdural software into a study.&nbsp;Funding and financialsIn March 2023, the company received USD 40 million from CIBC Innovation Banking. The funds were used to expand its platform.

Viz.ai offers an AI-powered integrated care coordination platform called Viz.ai One and develops diagnostic tools to support the early detection of deteriorating patient conditions by cross-referencing a patient’s CT images with its database of scans. The software then alerts healthcare providers and helps triage patients to specialists via its mobile app. The app also allows healthcare providers to view high-quality scans from any location.The Viz.ai One suite includes 1) Viz Vascular, tools for vascular medicine, 2) Viz Neuro, tools for suspected neuro diseases, 3) Viz Cardio, tools for cardiovascular needs, 4) Viz Trauma, 5) Viz Radiology, for radiologists, and 6) Viz Connect, a communication and workflow tool. In&nbsp;<a href="https://sp-edge.com/updates/35070">October 2024</a>, it launched a software incorporating natural language processing alongside imaging AI to enhance patient screening and follow-up for lung diseases.In 2021, Centers for Medicare &amp; Medicaid Service granted Viz.ai with the New Technology Add-On Payment, an industry first for AI technology in healthcare. This gives hospitals a maximum of USD 1,040 in additional payments per diagnosis for using its AI-enabled stroke intervention. The company has been rapidly expanding its offering, including the launch of a life science platform to perform clinical trials and support a go-to-market strategy.&nbsp;Key customers and partnershipsAs of May 2024, the company has partnered with 1,600 hospitals across the US, Europe, Middle-East and Africa for its AI driven platform.&nbsp;Further in November 2022, the company partnered with Singaporean-based software development company Us2.ai to offer echocardiogram analysis in the Viz Platform. In May 2024, Viz.ai announced the collaboration with the University of Texas Medical Branch (UTMB) to incorporate their Viz Subdural software into a study. Additionally, the company partnered with Cleerly in <a href="https://sp-edge.com/updates/33270">September 2024</a> to integrate Cleerly's AI software for coronary computed tomography angiography analysis into Viz.ai's One platform.

Cardiomo Care is developing noninvasive wearable devices to alert users and caretakers when there are abnormalities in the heartbeat. The company’s AI engine, trained on existing and growing data sets, can predict potential heart issues up to two hours before they occur, enabling early detection and intervention for arrhythmias and other cardiovascular diseases (CVDs).The company's product, CardiomoPatch, is a waterproof, wearable patch capable of long-term wear with a 10-day battery life. The patch monitors a patient's cardiac data, including ECG outputs, breathing, and skin temperature, and transmits the data via a mobile app for analysis by Cardiomo's AI engine.&nbsp;As of May 2024, the company is yet to commercialize its product and has over 1,600 pre-orders.

Cardiomo Care

Omada is a prevention-focused digital therapeutics startup that helps members achieve health goals through lifestyle changes. It offers four evidence-based, virtual prevention programs for managing hypertension, musculoskeletal (MSK) issues, prediabetes, and diabetes.Omada offers real-time data tracking through connected devices (such as wireless scales, blood pressure, and glucose monitors) and access to personalized coaching sessions via a mobile app as part of its prevention program. It also provides an online community of peers with similar health conditions to discuss challenges and provide support. In May 2021, Omada became the first fully-virtual healthcare provider to earn the National Committee for Quality Assurance’s Population Health Program Accreditation for its type 2 diabetes and type 2 diabetes + hypertension programs.Unlike its peers, Omada operates a performance-based business model where it charges clients an enrollment fee based on the number of users and a performance fee based on how much weight their employees lose. In May 2020, the company acquired virtual physical therapy startup Physera.Key customers and partnershipsAs of May 2024, Omada had more than 1 million members from more than 1,900 enterprise clients across all 50 US states. Its B2B employer and health plan client base include key clients such as American Eagle, Kaiser Permanente, Costco Wholesale, 3M, and Marvin. Additionally, the company has partnered with health systems and hospitals such as Intermountain Healthcare to provide its preventive programs as a covered benefit.In <a href="https://sp-edge.com/updates/15587">January 2023</a>, the company partnered with health service company Castell (a subsidiary of Intermountain Healthcare) to provide its diabetes programs to members from Intermountain Healthcare’s primary care providers in its Utah Medical Group. Further in <a href="https://sp-edge.com/updates/25245">January 2024</a>, the company partnered with Amazon to expand access to its cardiometabolic program.

Omada Health

VillageMD provides primary care services for patients. It also provides tools, technology, and staffing support needed for physicians to deliver high-quality services. VillageMD’s service delivery methods include traditional freestanding clinics, Village Medical at Walgreens co-located clinics, as well as at-home and around-the-clock virtual visits. It also leverages a team-based approach to care where physicians lead nurse practitioners, pharmacists, mental health specialists, and dietitians to offer a holistic care program. The technology of VillageMD includes docOS, an operating system that enables better patient care by connecting various clinical source systems with ongoing patient-generated data coupled with an AI engine to continuously analyze messages to enable patient self-care.The company made several acquisitions to expand its footprint: 1) <a href="https://sp-edge.com/updates/14347">Summit Health</a> for USD 8.9 billion in November 2022, 2) Healthy Interactions, an interactive patient education platform, in February 2022, and 3) <a href="https://sp-edge.com/updates/16968">Starling Physicians</a>, a primary care and specialty care provider, in March 2023.Key customers and partnershipsIn June 2020, VillageMD and Walgreens Boots Alliance announced a collaborative effort to open at least 600 Village Medical centers at Walgreens across more than 30 US markets by 2025. Walgreens invested USD 5.2 billion in VillageMD (from the previously announced USD 1.0 billion), raising its ownership stake to 63% (from 30%).However, as of May 2024, Walgreens had plans to close 160 VillageMD clinics as part of a cost-cutting plan.

VillageMD

Cityblock Health is a value-based healthcare provider focused on delivering comprehensive care to underserved communities, primarily Medicaid and lower-income Medicare beneficiaries. The company combines primary care, behavioral health, and social services to address the complex physical, mental, and social needs of its members.Cityblock's model involves partnering with local community-based organizations and deploying multidisciplinary care teams that include doctors, nurses, behavioral health specialists, and community health workers. These teams provide personalized care through 24/7 access to multi-modal care delivery, including in-home visits, telehealth, and community health hubs.The services of Cityblock are available to members at no additional cost if they are covered by an eligible health plan.Key Customers and PartnershipsAs of May 2024, the company’s services were available in seven states across the US and served over 100,000 members.In May 2024, it partnered with <a href="https://sp-edge.com/updates/29647">Sunshine Health</a> to expand to Florida, and, in <a href="https://sp-edge.com/updates/13270">September 2022</a>, it partnered with MDwise to expand into Indiana. Prior to that, the company had partnered with insurance providers such as ConnectiCare (Connecticut), Tufts Health Plan (Massachusetts), Emblem Health (New York), Healthy Blue (North Carolina), Molina Healthcare (Ohio) and CareFirst (Washington DC).Funding and FinancialsCityblock is a spin-off of Sidewalk Labs, an Alphabet company that incubates and invests in tech companies and products to improve urban infrastructure. It completed a USD 400 million Series D funding round led by Softbank in <a href="https://sp-edge.com/updates/5326">September 2021</a>, valuing the company at USD 5.7 billion. The funds were used to expand its services.

Cityblock Health

Everside Health (formerly Paladina Health) offers preventative care for chronic conditions and primary, mental and occupational healthcare treatments for acute conditions. Patients benefit from around-the-clock access to care, same-day or next-day appointments for in-person, and virtual care visits with zero copays.Everside aims to generate around 17% healthcare cost savings in three years and 31% in five years for its corporate members by leveraging a data-driven approach to care coordination.The company leverages data from past medical records, predictive analytics, and AI in the delivery of preventative care services.Founded in 2010 under the name Paladina Health, the company was rebranded in November 2020 as Everside Health following a merger between three primary care groups (Paladina, Activate Healthcare, and Healthstat). Furthermore, in February 2024, Everside Health merged with primary care provider Marathon Health to form a combined entity that would operate as Marathon Health, and, as of May 2024, the integration was ongoing.Key customers and partnershipPost-merger with Marathon Health, the combined entity would serve 2.5 million patients through over 680 clinics across 41 states.Funding and financialsThe company received its most recent investment in July 2022, amounting to USD 164 million in growth equity funding. The round was led by New Enterprise Associates (NEA). The funds were allocated toward growing its market presence and exploring opportunities for M&amp;A as well as to enhance and improve its product features. Additionally, the firm planned to expand its coverage of specialty care services aimed at individuals, employers, and union organizations.

Everside Health

Platforms offer a subscription-based or B2B-sponsored, evidence-based program for managing a specific long-term health condition.

DPCs offer value-based primary and preventive care services addressing whole-person (social, mental, physical) needs for a fixed monthly or annual fee paid by either the patient, insurance provider, or employer.

Companies offer B2B and D2C evidence-based treatments delivered via software programs to prevent and manage a variety of chronic conditions.

Companies offer independent physician practices and hospitals with the tools (patient engagement, care coordination, administrative services) to help manage and improve clinical health outcomes of a defined group of individuals or large populations.

Platforms are used to track and gather patient health-related information via either a connected device or at-home test kits to detect the early onset of disease and identify any abnormalities in readings—but do not include a treatment plan.

To gather large amounts of real-time data for chronic care management, DTx, and patient monitoring

XR used by some startups for chronic pain management

Offers digital means of providing direct primary care, passive remote monitoring, chronic care management, etc.

AI/ML is used in predictive analytics, diagnostics tools, and population management

Offers tailored preventive interventions and treatments to the specific needs and characteristics of each individual

PROMINENT_CATEGORY

<div>
 
 AI-based platform, Viz.ai, has boosted its lung disease software functionalities. The updated software leverages natural language processing (NLP) and imaging AI to optimize patient screening and tracking for lung diseases.
 The advanced software will extract clinical data from electronic health records (EHR) and detect and supervise patients with lung disease. It will be incorporated into Viz.ai's current platform to expedite the care process, intending to diminish the treatment time and enhance patient outcomes.
 
</div>

Viz.ai

EDGE Insights

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless